Rare diseases
Investigational molecules
Locations
1 North Wacker Drive Suite 1650, 60606-2807, United States
Quetzal Therapeutics LLC is focused on acute promyelocytic leukemia, with clinical activity centered on adult patients affected by this blood cancer. The sponsor’s research interest lies in treatment approaches for leukemia within the broader field of hematologic malignancies.
The clinical program includes work across multiple research sites in the United States and other active countries, reflecting an emphasis on specialist care for this rare leukemia subtype.
Quetzal Therapeutics LLC runs clinical trials in conditions such as Acute promyelocytic leukaemia, among others.
Clinical trials run by this sponsor – those enrolling participants first.
QTX-2101 and Arsenic Trioxide in Adult Patients With Acute Promyelocytic Leukemia
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
